Detecting Fraud and Anti-Competitive Behaviour in the Australian Pharmaceutical and Medical Device Industries

检测澳大利亚制药和医疗器械行业的欺诈和反竞争行为

• 批准号: DP1092584
• 负责人: Prof Dr Thomas Faunce
• 金额: $ 8.8万
• 依托单位: The Australian National University
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2010
• 资助国家: 澳大利亚
• 起止时间: 2010-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP1092584
• 关键词: Detecting; Fraud; Anti; Competitive; Behaviour

This Project will deliver law reform proposals to ensure greater accountability and a reduction of fraud and anti-competitive behaviour associated with over 6 billion dollars of public money expended each year under the Pharmaceutical Benefits Scheme (PBS) as well as significant amounts paid by public hospitals on medical devices. It unites experts in Australian pharmaceutical regulation and high technology law enforcement with an eminent United States Partner Investigator in False Claims litigation. Reducing fraud and anti-competitive behaviour could be critical to survivability of the PBS and the benefits it brings particularly to an ageing population.

该项目将提出法律改革建议，以确保加强问责制，减少与每年在药品福利计划下花费的60多亿美元公共资金以及公立医院在医疗设备上支付的大量费用有关的欺诈和反竞争行为。它将澳大利亚制药监管和高科技执法领域的专家与一位著名的美国虚假索赔诉讼合作调查员联合起来。减少欺诈和反竞争行为可能对公共广播系统的生存及其带来的好处至关重要，特别是对老龄化人口。